AR003414A1 - Uso de derivados de imidazol [1,2-a]piridina -3-acetamida y una composicion farmaceutica que comprende tal derivado - Google Patents
Uso de derivados de imidazol [1,2-a]piridina -3-acetamida y una composicion farmaceutica que comprende tal derivadoInfo
- Publication number
- AR003414A1 AR003414A1 ARP960102094A AR10209496A AR003414A1 AR 003414 A1 AR003414 A1 AR 003414A1 AR P960102094 A ARP960102094 A AR P960102094A AR 10209496 A AR10209496 A AR 10209496A AR 003414 A1 AR003414 A1 AR 003414A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- hydrogen
- derivative
- pharmaceutical composition
- halogen atom
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Dichos derivados responden a la fórmula general (I), en donde: Y representa un átomo de hidrógeno o halógeno o un grupo alquilo C1-4; A representa unradical naftilo o un radical (II) en donde cada uno de X1 y X2 independientementeen tre sí es un átomo de hidrógeno o halógeno, un grupoalcoxi C1-4, un grupo alquilo C1-6 ó CF3, CH3S-, CH3SO2- ó -NO2, y cada uno de R1 y R2 independientemente entre sí representa o bien un átomo de hidrógeno,o un grupo alquilo C1-5 recto oramific ado que no está substituido o que está substituido por uno o más átomos de halógeno,grupos hidroxilo,-N(C1-4 alquilo)2, carbamoilo o alcoxi C1-4, o un grupo alilo, o un grupo propargilo, o un grupo cicloalquilo C3-6, o un grupobencilo, o un grupo fenilo, no siendosambos R1 y R2 hidrógeno, o -NR1R2 representa un anillo heterocíclico que contiene de 3 a 6 átomos de carbono, o un anillo heterocíclico de la fórmula(III), en donde X es O, S, CHOR ó N-R, siendo Rhidrógeno o bencilo y siendo R hidrógeno, un grupo alquilo C1-4, o fenilo que no está substituido o queestá substituido por metoxi o un átomo de halógeno. Además, la invención se refiere a una composición farmacéutica que comprende talderivado.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95RM000223A IT1276522B1 (it) | 1995-04-07 | 1995-04-07 | Uso dello zolpidem per il trattamento terapeudico di sindromi neuropsichiatriche associate a disfunsione e di circuiti neurali dei |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR003414A1 true AR003414A1 (es) | 1998-08-05 |
Family
ID=11403250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960102094A AR003414A1 (es) | 1995-04-07 | 1996-04-08 | Uso de derivados de imidazol [1,2-a]piridina -3-acetamida y una composicion farmaceutica que comprende tal derivado |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5891891A (es) |
| EP (1) | EP0819002B1 (es) |
| JP (1) | JP4049390B2 (es) |
| KR (1) | KR100425628B1 (es) |
| CN (1) | CN1198612C (es) |
| AR (1) | AR003414A1 (es) |
| AT (1) | ATE222763T1 (es) |
| AU (1) | AU707759B2 (es) |
| CA (1) | CA2217590C (es) |
| CZ (1) | CZ292020B6 (es) |
| DE (1) | DE69623271T2 (es) |
| DK (1) | DK0819002T3 (es) |
| EA (1) | EA000396B1 (es) |
| ES (1) | ES2182967T3 (es) |
| HU (1) | HUP9900733A3 (es) |
| IL (1) | IL117824A (es) |
| IT (1) | IT1276522B1 (es) |
| MX (1) | MX9707712A (es) |
| NO (1) | NO315408B1 (es) |
| NZ (1) | NZ304107A (es) |
| PL (1) | PL322647A1 (es) |
| PT (1) | PT819002E (es) |
| TW (1) | TW450816B (es) |
| WO (1) | WO1996031210A1 (es) |
| ZA (1) | ZA962711B (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7632517B2 (en) * | 1997-10-01 | 2009-12-15 | Novadel Pharma Inc. | Buccal, polar and non-polar spray containing zolpidem |
| US6333345B1 (en) | 1999-05-14 | 2001-12-25 | Sepracor, Inc. | Methods of using and compositions comprising N-desmethylzolpidem |
| US6399621B1 (en) | 1999-08-10 | 2002-06-04 | American Cyanamid Company | N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
| US20030091632A1 (en) * | 1999-08-26 | 2003-05-15 | Neurocrine Biosciences, Inc. | Controlled-release sedative-hypnotic compositions and methods related thereto |
| US6485746B1 (en) | 2000-08-25 | 2002-11-26 | Neurocrine Biosciences, Inc. | Controlled-release sedative-hypnotic compositions and methods related thereto |
| US6384221B1 (en) | 1999-09-02 | 2002-05-07 | Neurocrine Biosciences, Inc. | Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
| AU5066101A (en) * | 2000-04-13 | 2001-10-30 | Synthon B.V. | Modified release formulations containing a hypnotic agent |
| DE20122435U1 (de) * | 2000-04-24 | 2005-10-06 | Teva Pharmaceutical Industries Ltd. | Mikronisiertes Zolpidem-Hemitartrat |
| DE10041478A1 (de) * | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
| DE10117183A1 (de) * | 2001-04-05 | 2002-10-10 | Gruenenthal Gmbh | Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel |
| GB0311457D0 (en) * | 2003-05-19 | 2003-06-25 | Sciencom Ltd | New therapeutic use |
| JP2008506630A (ja) * | 2003-05-19 | 2008-03-06 | サイエンコム・リミテッド | ゾルピデムの更なる治療的使用 |
| DE10334187A1 (de) * | 2003-07-26 | 2005-03-03 | Schwarz Pharma Ag | Substituierte 2-Aminotetraline zur Behandlung von Depressionen |
| DE10334188B4 (de) | 2003-07-26 | 2007-07-05 | Schwarz Pharma Ag | Verwendung von Rotigotin zur Behandlung von Depressionen |
| PL1691811T3 (pl) | 2003-12-11 | 2014-12-31 | Sunovion Pharmaceuticals Inc | Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji |
| DE10361258A1 (de) | 2003-12-24 | 2005-07-28 | Schwarz Pharma Ag | Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson |
| DE602005018763D1 (de) | 2004-02-18 | 2010-02-25 | Sepracor Inc | Dopamin-agonisten-kombinationstherapie mit sedativa zur verbesserung der schlafqualität |
| DE102004014841B4 (de) | 2004-03-24 | 2006-07-06 | Schwarz Pharma Ag | Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms |
| DE602006008339D1 (en) * | 2005-11-18 | 2009-09-17 | Synhton B V | Zolpidemtabletten |
| GB2443928A (en) * | 2006-11-08 | 2008-05-21 | Regen Therapeutics Plc | Transdermal pharmaceutical composition comprising Zolpidem |
| GB0809936D0 (en) * | 2008-05-30 | 2008-07-09 | Regen Therapeutics Plc | Therapeutic use of zolpidem |
| WO2017214442A1 (en) | 2016-06-08 | 2017-12-14 | President And Fellows Of Harvard College | Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, rett syndrome, and fragile x syndrome |
| US11434244B2 (en) | 2018-05-29 | 2022-09-06 | President And Fellows Of Harvard College | Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2492382A1 (fr) * | 1980-10-22 | 1982-04-23 | Synthelabo | Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique |
| US5032595A (en) * | 1989-11-24 | 1991-07-16 | Fidia-Georgetown Institute For The Neurosciences | Method of stimulating steroidogenesis with alpidem |
| US5206382A (en) * | 1991-06-27 | 1993-04-27 | Fidia Georgetown Institute For The Neurosciences | Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders |
-
1995
- 1995-04-07 IT IT95RM000223A patent/IT1276522B1/it active IP Right Grant
-
1996
- 1996-04-02 HU HU9900733A patent/HUP9900733A3/hu unknown
- 1996-04-02 AU AU51200/96A patent/AU707759B2/en not_active Ceased
- 1996-04-02 NZ NZ304107A patent/NZ304107A/xx not_active IP Right Cessation
- 1996-04-02 PT PT96907656T patent/PT819002E/pt unknown
- 1996-04-02 WO PCT/IT1996/000063 patent/WO1996031210A1/en active IP Right Grant
- 1996-04-02 CA CA002217590A patent/CA2217590C/en not_active Expired - Lifetime
- 1996-04-02 DE DE69623271T patent/DE69623271T2/de not_active Expired - Lifetime
- 1996-04-02 KR KR1019970707107A patent/KR100425628B1/ko not_active IP Right Cessation
- 1996-04-02 CN CNB961937815A patent/CN1198612C/zh not_active Expired - Fee Related
- 1996-04-02 EA EA199700308A patent/EA000396B1/ru not_active IP Right Cessation
- 1996-04-02 MX MX9707712A patent/MX9707712A/es unknown
- 1996-04-02 US US08/930,644 patent/US5891891A/en not_active Expired - Lifetime
- 1996-04-02 JP JP53016596A patent/JP4049390B2/ja not_active Expired - Fee Related
- 1996-04-02 ES ES96907656T patent/ES2182967T3/es not_active Expired - Lifetime
- 1996-04-02 AT AT96907656T patent/ATE222763T1/de active
- 1996-04-02 DK DK96907656T patent/DK0819002T3/da active
- 1996-04-02 EP EP96907656A patent/EP0819002B1/en not_active Expired - Lifetime
- 1996-04-02 PL PL96322647A patent/PL322647A1/xx unknown
- 1996-04-02 CZ CZ19973167A patent/CZ292020B6/cs not_active IP Right Cessation
- 1996-04-03 IL IL11782496A patent/IL117824A/xx not_active IP Right Cessation
- 1996-04-04 ZA ZA962711A patent/ZA962711B/xx unknown
- 1996-04-08 AR ARP960102094A patent/AR003414A1/es unknown
- 1996-04-15 TW TW085104484A patent/TW450816B/zh not_active IP Right Cessation
-
1997
- 1997-10-06 NO NO19974603A patent/NO315408B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR003414A1 (es) | Uso de derivados de imidazol [1,2-a]piridina -3-acetamida y una composicion farmaceutica que comprende tal derivado | |
| DK0783500T3 (da) | Aminoheterocykliske derivater som antithrombotiske eller antikoagulerende midler | |
| ES2188194T3 (es) | 1,8-naftiridin-4(1h)-onas sustituidas como inhibidores de la fosfodiesterasa 4. | |
| ES2168953A1 (es) | Derivados de oxima y su uso como acidos latentes | |
| DK0861228T3 (da) | Lipopolyaminer som transfektionsmidler samt deres farmaceutiske anvendelser | |
| NO982606L (no) | Naftylsubstituerte benzimidazolderivater som antikoagulanter | |
| DK164701C (da) | Thiazolidinderivater, deres fremstilling og midler, som indeholder dem | |
| ES2069137T3 (es) | Derivados de imidazopiridina y su uso. | |
| AR002012A1 (es) | Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto. | |
| DK57492A (da) | Farmaceutiske praeparater af n-phenylbenzamidderivater | |
| TW333527B (en) | Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them | |
| NO20022232L (no) | Imidazolforbindelser for anvendelse som inhibitorer for fosfodiesterase VII | |
| ES2045485T3 (es) | Metodo de preparacion de derivados de fenil-6 piperazinilalquil-3 1h, 3h-pirimidinediona-2,4, y su aplicacion en terapeutica. | |
| FI824531A0 (fi) | N-oxid-foereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat | |
| MX9204179A (es) | Derivados de imidazo(2,1-b)benzotiazola-3-acetamida, su preparacion y su aplicacion en terapeutica. | |
| AR012990A1 (es) | Compuestos de benzo(5,6) cicloheptapiridina, composiciones farmaceuticas que los contienen, y el uso de dichos compuestos como inhibidores de laproteina farnesil transferasa. | |
| DK0861250T3 (da) | Amindin- og isothiourinstofderivater som inhibitorer for nitrogenmonoxidsyntase | |
| IL74800A0 (en) | Tetrahydrothienopyridines,their preparation and pharmaceutical compositions containing them | |
| DK0486385T3 (da) | Imidazolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| DK0906295T3 (da) | Dibenzo-oxazepin- og -dioxepinderivater og deres anvendelse som anti-tumormidler | |
| DE3161553D1 (en) | Thiazolo(3,2-a)pyrimidine derivatives, their preparation and pharmaceutical compositions containing them | |
| SE8603589L (sv) | Metylendioxifenantren- och stilbenderivat | |
| DK0782574T3 (da) | Bicycliske carboxiamider som 5-HT1A-receptorligander | |
| ES2096931T3 (es) | Derivados de 4-oxa-1-azabiciclo(3,2,0)heptan-7-ona utilizados como agentes antitumorales. | |
| GB2276619A (en) | Cyclic ketal derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |